English
This article is from International Journal of Pharmaceutical Investigation , volume 1 . Abstract Background and Aim:: Momordica charantia Linn. is traditionally used as a medicine for diabetes. The present investigation was aimed to formulate and evaluate transdermal patchesof Momordica charantia Linn. Materials and Methods:: The transdermal films containing the herbal drug component fractionated fromethanolicextract of M. charantia fruits were prepared by using hydroxy propyl methyl cellulose as a polymer. The films were evaluated for folding endurance, thickness, weight variation, drug contents and in vitro diffusion studies and in vivo parameterslike acute and sub-acute antihyperglycemic activity in diabetic rats, biochemicalstudies, skin irritation in rats and stability studies. Result and discussion:: The weightof transdermal patches of M. charantia (2 cm2; 10 mg/patch) and was found to be 0.03 gm.Thickness of patches of M. charantia (2 cm2; 10 mg/patch) was found to be satisfactory. The percentage release of active constituents from transdermal patches of M.charantia (2 cm2; 10 mg/patch) was found to be 47.59% in 10% hydroalcoholic phosphate buffer pH 7.4 at the end of 6 h.Th
Sign in with your free account to read, download EPUBs or listen.
Ebook · A novel herbal formulation in the management of diabetes. · Bhujbal, Santosh S, Hadawale, Sunita S, Kulkarni, Parag A, Bidkar, Jayant S, Thatte, Vidya A, Providencia, Clarine A, Yeola, Rupesh R · Internet Archive